Skip to main content

Table 1 Estimated burden of rare variants in cases and controls, for the calculation of prior odds of pathogenicity

From: Bayesian models for syndrome- and gene-specific probabilities of novel variant pathogenicity

  

Non-radical variants

Radical variants

 

Gene

Syndrome

Burden in

Burden in

Prior

Burden in

Burden in

Prior

Case burden in literature

  

case series

controls

odds

case series

controls

odds

(combined radical and

        

non-radical variants)

KCNQ1

LQTS

0.1784

0.0039

45

0.0384

0.0002

191

0.421

KCNH2

LQTS

0.1256

0.0048

25

0.0392

0

195

0.388

SCN5A

LQTS

0.0584

0.0112

4

0.0028

0.0002

13

0.090

KCNE1

LQTS

0.0124

0.0014

8

0.0020

0

9

0.010

KCNE2

LQTS

0.0052

0.0011

4

0.0004

0.0002

1

0.010

KCNJ2

LQTS

 

0.0026

0.92

 

0

0.2

0.010

ANK2

LQTS

 

0.0386

0.2

 

0

0.2

0.010

CACNA1C

LQTS

 

0.0112

0.2

 

0

0.2

0.010

CAV3

LQTS

 

0.0011

4

 

0.0002

0.2

0.010

SCN4B

LQTS

 

0.0017

0.2

 

0.0006

0.2

0.001

AKAP9

LQTS

 

0.0393

0.2

 

0.0005

0.2

0.001

SNTA1

LQTS

 

0.0043

0.2

 

0.0003

0.2

0.001

KCNJ5

LQTS

 

0.0045

0.2

 

0

0.2

0.001

MYBPC3

HCM

  

37.5

  

37.5

0.375

MYH7

HCM

  

25

  

25

0.250

TNNT2

HCM

  

6

  

6

0.060

TNNI3

HCM

  

6

  

6

0.060

SCN5A

BrS

  

30

  

30

0.300

CACNA1C

BrS

  

1

  

1

0.010

CACNA2D1

BrS

  

1

  

1

0.010

CACNB2

BrS

  

1

  

1

0.010

GPD1L

BrS

  

1

  

1

0.010

KCND3

BrS

  

1

  

1

0.010

KCNE3

BrS

  

1

  

1

0.010

SCN1B

BrS

  

1

  

1

0.010

SCN3B

BrS

  

1

  

1

0.010

  1. The estimated burden of rare variants in genes for LQTS, HCM and BrS in cases and ESP controls, where rare corresponds to an allele frequency <0.0005. Burdens are given as proportions (range 0-1). Values are presented for radical (truncating) variants and for inframe indels and missense substitutions combined (non-radical variants). For all genes, an estimate of the burden in cases is derived from the literature. For five LQTS genes, the burden in cases is estimated both from literature reports and from a prospective case series; the latter are used in our model where available. Otherwise half the literature-based estimate is used for LQTS genes (see text for discussion). Zero values of control frequencies are replaced by 0.0002 to compute ratios. For HCM and BrS the burden in cases is taken from the literature, and the burden in controls is fixed at 0.01.